Bupa has confirmed the sale of its Home Healthcare business to Celesio.
Celesio UK is a leading provider of integrated healthcare services to the NHS specialising in medicines, pharmaceutical care and primary care patient services.
The company owns LloydsPharmacy, AAH Pharmaceuticals, Evolution Homecare, LloydsPharmacy Online Doctor and Betterlife.
The acquisition, which is subject to regulatory approval, will see Celesio expand its home healthcare operation.
The addition of Bupa Home Healthcare to Celesio UK will complement existing services and strengthen the company’s national healthcare infrastructure, enabling patients to benefit from greater flexibility and more choice, the company says.
Marc Owen, chairman of the management board of Celesio Group, explains: “We look forward to welcoming our new colleagues to the Celesio family. Bupa Home Healthcare is an excellent addition to our business as we share the same values, where patients come first, and we both strive to help patients live more fulfilling lives.
“As the population continues to age and the number of people requiring speciality medicines increases it is vital we invest in home healthcare solutions to help the NHS meet demand both now and in the future. Bupa Home Healthcare joining the Celesio family will enable us to enhance our clinical homecare offering and provide a broader set of services.”
Richard Bowden, Bupa UK managing director, adds: “Bupa Home Healthcare is a great fit for Celesio which has a long term commitment to clinical home healthcare and shares our dedication to patients, customers and employees and focus on delivering high quality care.”